Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.02
+2.00%
Mkt Cap $42.32M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+2429.1%
Consensus $25.67 vs current $1.02
NYSE·Healthcare·Biotechnology
$1.02
+2.00%
Mkt Cap $42.32M
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+2429.1%
Consensus $25.67 vs current $1.02